55 related articles for article (PubMed ID: 125022)
1. [Sulphated glycosaminoglycans as virus inhibitors. 2nd communication: Inhibitory effect of glycosaminoglycanpolysulphates on yellow fever virus 17 D in animal experiments (author's transl)].
Museteanu C; Voss H; Rossner R
Zentralbl Bakteriol Orig A; 1975; 230(3):298-305. PubMed ID: 125022
[TBL] [Abstract][Full Text] [Related]
2. [Sulphated glycosaminoglycans as virus inhibitors. 3rd communication: therapy of viral diseases by means of glycoasaminoglycanpolysulphates. Establishment of fundamentals in experiments with laboratory animals (author's transl)].
Muşeţeanu C; Voss H
Zentralbl Bakteriol Orig A; 1975 May; 231(4):375-88. PubMed ID: 126622
[TBL] [Abstract][Full Text] [Related]
3. [Sulphated glycosaminoglycans as virus inhibitors. 1st communication: The effect of sulphated glycosaminoglycans in different virus-host systems as demonstrated by the plaque inhibition test (author's transl)].
Voss H; Sensch KH; Panse P
Zentralbl Bakteriol Orig A; 1974; 229(1):1-36. PubMed ID: 4155203
[No Abstract] [Full Text] [Related]
4. [Abnormality in the behaviour of mice after an experimental encephalitis by yellow fever virus 17 D. Experiment model(author's transl)].
Henneberg G; Haase J; Museteanu C; Zausch GT
Zentralbl Bakteriol Orig A; 1976 Jan; 234(1):1-13. PubMed ID: 1258562
[TBL] [Abstract][Full Text] [Related]
5. [Decrease in efficiency after experimental virus encephalitis. Small scale experimental tests on mice and histologic evaluation (author's transl)].
Welte M
Zentralbl Bakteriol Orig A; 1976 Dec; 236(4):439-63. PubMed ID: 1015029
[TBL] [Abstract][Full Text] [Related]
6. [A contribution to infection with yellow fever virus 17D in chick embryos (author's transl)].
Tinnefeld L; Haase J; Museteanu C
Zentralbl Bakteriol Orig A; 1977 Apr; 237(4):453-69. PubMed ID: 559399
[TBL] [Abstract][Full Text] [Related]
7. [Long-term infection of a cell culture from newborn mouse brain with the FNV strain of yellow fever virus (author's transl)].
Fleury H; Adam C; Heme G
Ann Microbiol (Paris); 1977; 128B(4):541-5. PubMed ID: 565183
[TBL] [Abstract][Full Text] [Related]
8. [Sulphated glycosaminoglycans as virus inhibitors. 4th communication: clinical aspects of zoster with the proposal of a new treatment (author's transl)].
Voss H; Pohle HD; Museteanu C
Zentralbl Bakteriol Orig A; 1977 Feb; 237(1):1-34. PubMed ID: 190822
[TBL] [Abstract][Full Text] [Related]
9. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
[TBL] [Abstract][Full Text] [Related]
10. Partial inhibition of yellow fever virus replication in vitro with different phosphorothioate oligodeoxyribonucleotides.
Tolou H; Puggelli H; Tock F; Durand JP
Acta Virol; 1996 Apr; 40(2):73-9. PubMed ID: 8886115
[TBL] [Abstract][Full Text] [Related]
11. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
Leyssen P; De Clercq E; Neyts J
Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
[TBL] [Abstract][Full Text] [Related]
12. [Lesions in the central nervous system of the mouse caused by yellow fever 17 D. An animal model of the histological evaluation of viral encephalitis (author's transl)].
Rodloff AC
Zentralbl Bakteriol A; 1981; 249(2):152-61. PubMed ID: 7269849
[TBL] [Abstract][Full Text] [Related]
13. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum inhibitor of viruses in the Flaviviridae family.
Ojwang JO; Ali S; Smee DF; Morrey JD; Shimasaki CD; Sidwell RW
Antiviral Res; 2005 Nov; 68(2):49-55. PubMed ID: 16199098
[TBL] [Abstract][Full Text] [Related]
17. [Molecular detection of yellow fever virus in human sera and mice brains].
Méndez JA; Rodríguez G; Bernal Mdel P; de Calvache D; Boshell J
Biomedica; 2003 Jun; 23(2):232-8. PubMed ID: 12872563
[TBL] [Abstract][Full Text] [Related]
18. [Effect of neonatal thymectomy on encephalic lesions of newborn mice infected with yellow fever virus].
Besuschio SC; Weissenbacher MC; Schmuñis GA
Medicina (B Aires); 1976; 36(3):193-6. PubMed ID: 966988
[No Abstract] [Full Text] [Related]
19. [The influence of artificial infrared radiation and microwaves upon mucopolysaccharides, protamine sulphate, and mucin in virus-infected organ cultures (author's transl)].
Henneberg G; Heller S; Jordanski H
Zentralbl Bakteriol A; 1980 Mar; 246(2):167-83. PubMed ID: 6448527
[TBL] [Abstract][Full Text] [Related]
20. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.
Gaspar LP; Mendes YS; Yamamura AM; Almeida LF; Caride E; Gonçalves RB; Silva JL; Oliveira AC; Galler R; Freire MS
J Virol Methods; 2008 Jun; 150(1-2):57-62. PubMed ID: 18420285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
